|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Frovatriptan#Adult Indications and Dosage]] |
| {{Frovatriptan}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Indications and Usage==
| |
| FROVA is indicated for the acute treatment of migraine with or without aura in adults.
| |
| | |
| '''Limitations of Use'''
| |
| | |
| *Use only if a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with FROVA, reconsider the diagnosis of migraine before FROVA is administered to treat any subsequent attacks.
| |
| | |
| *FROVA is not indicated for the prevention of migraine attacks.
| |
| | |
| *Safety and effectiveness of FROVA have not been established for cluster headache.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FROVA (FROVATRIPTAN SUCCINATE) TABLET, FILM COATED [ENDO PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0703630-9ce8-4259-841e-71fd2019fa66 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Antimigraine drugs]]
| |
| [[Category:Triptans]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |